These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 4570944)

  • 21. Cytocidal effect of dimethyl sulfoxide on normal and leukemic lymphocytes.
    Schrek R; Elrod LM; Batra KV
    Ann N Y Acad Sci; 1967 Mar; 141(1):202-13. PubMed ID: 5342257
    [No Abstract]   [Full Text] [Related]  

  • 22. A monoclonal antibody with reactivity restricted to normal and neoplastic plasma cells.
    Anderson KC; Bates MP; Slaughenhoupt B; Schlossman SF; Nadler LM
    J Immunol; 1984 Jun; 132(6):3172-9. PubMed ID: 6427334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Malignant lymphomas.
    Tindle BH
    Am J Pathol; 1984 Jul; 116(1):119-74. PubMed ID: 6377907
    [No Abstract]   [Full Text] [Related]  

  • 24. [A new physio-morphological approach to malignant non hodgkinian lymphomas].
    Cabanne PF
    Bull Cancer; 1974; 61(1):1-9. PubMed ID: 4617605
    [No Abstract]   [Full Text] [Related]  

  • 25. Atypical lymphoid hyperplasia mimicking lymphoma.
    Good DJ; Gascoyne RD
    Hematol Oncol Clin North Am; 2009 Aug; 23(4):729-45. PubMed ID: 19577167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [What is reliable in the therapy of hematologic diseases? I. Hemoblastosis and malignant lymphoproliferative diseases].
    Havemann K; Schmidt M; Malchow H; Sodomann CP
    Internist (Berl); 1970 Dec; 11(12):441-9. PubMed ID: 4993105
    [No Abstract]   [Full Text] [Related]  

  • 27. Cytogenetic approaches to the clarification of pathogenesis in lymphoid malignancies: clinicopathologic characterization of 14q+ marker-positive non-T-cell malignancies.
    Fukuhara S; Nasu K; Kita K; Ueshima Y; Oguma S; Yamabe H; Nishigori M; Uchino H
    Jpn J Clin Oncol; 1983 Sep; 13(3):461-75. PubMed ID: 6580474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new model for leukemia-lymphoma metastasis: differential growth and rejection of murine lymphoid-leukemia cell lines in the bone marrow.
    Kamenov B; Kieran MW; Leigh JB; Greenberg AH; Longenecker BM
    Symp Fundam Cancer Res; 1983; 36():245-64. PubMed ID: 6679093
    [No Abstract]   [Full Text] [Related]  

  • 29. Loss of CD19 expression in B-cell neoplasms.
    Masir N; Marafioti T; Jones M; Natkunam Y; Rüdiger T; Hansmann ML; Mason DY
    Histopathology; 2006 Feb; 48(3):239-46. PubMed ID: 16430470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PRDM1/BLIMP-1 expression in multiple B and T-cell lymphoma.
    Garcia JF; Roncador G; García JF; Sánz AI; Maestre L; Lucas E; Montes-Moreno S; Fernandez Victoria R; Martinez-Torrecuadrara JL; Marafioti T; Mason DY; Piris MA
    Haematologica; 2006 Apr; 91(4):467-74. PubMed ID: 16585013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Splenectomy in malignant lymphoma and leukemia.
    Mittelman A; Stutzman L; Grace JT
    Geriatrics; 1968 May; 23(5):142-9. PubMed ID: 4869007
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical patterns in B lymphoid malignancy.
    Galton DA; MacLennan IC
    Clin Haematol; 1982 Oct; 11(3):561-87. PubMed ID: 6756734
    [No Abstract]   [Full Text] [Related]  

  • 33. Some ultrastructural aspect of T and B lymphocytes and their significance in chronic internal diseases with immune component.
    Micu D; Manolescu N
    Med Interne; 1982; 20(1):3-8. PubMed ID: 6981833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Reactivity of the lymphocytes of lymph nodes in cases of malignant lymphoma to plant agglutinin].
    Stramignoni A; Navone R; Meriggi E
    Boll Soc Ital Biol Sper; 1969 Feb; 45(3):194-6. PubMed ID: 4899663
    [No Abstract]   [Full Text] [Related]  

  • 35. T and B lymphocyte enumeration in the diagnosis of lymphocyte-rich pleural fluids.
    Domagała W; Emeson EE; Koss LG
    Acta Cytol; 1981; 25(2):108-10. PubMed ID: 6972683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [New viewpoints for indication for radiologic treatment in leukoses and retikuloses].
    Musshoff K
    Strahlentherapie; 1968 Jun; 135(6):641-55. PubMed ID: 4878792
    [No Abstract]   [Full Text] [Related]  

  • 37. [Blastic lymphocyte transformation caused by phytohemagglutinin in patients with lymphoproliferative diseases].
    Mantovani G; Petrini MT; Tognella S; Grifoni V
    Boll Soc Ital Biol Sper; 1972 Jul; 48(14):381-5. PubMed ID: 4628299
    [No Abstract]   [Full Text] [Related]  

  • 38. Expression of Grb2 distinguishes classical Hodgkin lymphomas from primary mediastinal B-cell lymphomas and other diffuse large B-cell lymphomas.
    Miles RR; Mankey CC; Seiler CE; Smith LB; Teruya-Feldstein J; Hsi ED; Elenitoba-Johnson KS; Lim MS
    Hum Pathol; 2009 Dec; 40(12):1731-7. PubMed ID: 19716163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Demonstration of the Y fluorescent corpuscule at the level of normal and pathological cells].
    Lessard M; Rivière D
    C R Seances Soc Biol Fil; 1971; 165(7):1743-6. PubMed ID: 4261941
    [No Abstract]   [Full Text] [Related]  

  • 40. An in vitro model for tumor progression in murine lymphoid cells.
    Schwartz RC; Stanton LW; Marcu KB; Witte ON
    Curr Top Microbiol Immunol; 1986; 132():75-80. PubMed ID: 3491739
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.